Open Access

ARTICLE

Uropharmacology in primary care: 2010 update

Leonard G. Gomella¹, Costas D. Lallas¹, Robert Perkel², Christine Folia³, Irvin Hirsch¹, Akhil Das¹, Patrick Shenot¹

1 Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
2 Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
3 Department of Pharmacy, Hamilton Health Sciences, Hamilton, Ontario, Canada
Address correspondence to Dr. Leonard G. Gomella, Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, 1025 Walnut Street, Suite 1112 College Building, Philadelphia, PA 19107 USA

Canadian Journal of Urology 2010, 17(Suppl.1), 35-51.

Abstract

Many disorders such as erectile dysfunction, overactive bladder, hypogonadism and benign prostatic hypertrophy have traditionally been managed primarily by urologists. The development of newer agents to treat many of these conditions has allowed the primary care provider to manage many of these common conditions. The use of these newer medications has become commonplace in the primary care setting. This article will update some of the most commonly used urologic medications to optimize patient management strategies by the primary care provider or in coordination with the urologist.

---

Keywords

---